Viome Life Sciences

Viome Life Sciences is a health and longevity company founded in 2016. It digitizes, decodes and analyses human biology with the aim of preventing, diagnosing early and treating chronic diseases and cancer. Its work sits at the intersection of precision medicine and consumer health, combining laboratory analysis, data science and personalised guidance delivered directly to individuals.

The company's direct-to-consumer test analyses both microbial and human gene expression (mRNA), which it describes as the only such test of its kind in the industry. Results feed an artificial-intelligence platform that produces personalised food recommendations, precision supplement suggestions and actionable health insights tailored to an individual's biology. The underlying dataset comprises more than 600,000 samples. Its stated method blends what it calls Biological Intelligence, Human Intelligence and Artificial Intelligence.

Technical work spans artificial intelligence, genomics and gene expression analysis, microbiome analysis, bioinformatics, precision medicine and digital health. The broader operation touches healthcare, biotechnology, diagnostics, and nutrition and supplements. The company describes its culture as mission-driven and oriented towards eradicating chronic disease; the founder, Naveen Jain, framed the work as a decade-long mission following his earlier work with Moon Express on a lunar landing. An underlying ethos is giving people the information to live healthier lives.